Form DEF 14A ORACLE CORP For: Nov 15 streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Form DEF 14A Dynatrace, Inc. For: Aug 23 streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
PROPOSAL 5 -APPROVAL OF CEO RSU General The Board recommends that our stockholders approve (i) the cancellation of the performance-based stock option to purchase up to 3,122,931 shar.
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
Chief Financial. | August 26, 2022
Message :
Required fields
Company”), a molecular diagnostics company that develops fully automated rapid pathogen detection systems, is pleased to announce it is taking steps to list its common shares on the Nasdaq Capital Market with the goal of submitting its application prior to the end of 2021. A successful listing on the Nasdaq will make the Company’s shares more accessible to retail and institutional investors in the United States and internationally as well as increase share liquidity. The Nasdaq is the Company’s preferred Exchange as it hosts the best biotech and life science companies in the world.
LexaGene has taken several steps to prepare for a Nasdaq listing application.